Clinical Trials on Angiogenesis Modulated by EPC

Total 61 results

Chang Gung Memorial Hospital
National Science Council, Taiwan; Chang Gung University

Unknown

Effects of Aerobic Interval and Continuous Exercise Trainings in Patients With Chronic Heart Failure

Cardiac and Hemodynamic Response | Blood Flow Distribution and Oxygen Uptake Efficiency | Hemorheology Modulated by Erythrocyte | Atherothrombosis Modulated by Monocyte | Angiogenesis Modulated by EPC

Taiwan
University of Vermont

Completed

The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy

Breast Cancer | Angiogenesis

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer

Breast Cancer | Tumor Angiogenesis

Israel
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer

Stomach Neoplasms | Radiotherapy, Intensity-Modulated | Chemoradiotherapy, Adjuvant

China
Fujian Cancer Hospital

Unknown

The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

Breast Cancer | Angiogenesis
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma

Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound Complications | Targetd Therapy

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma

Anlotinib | Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound Complications

China
Xue Xiaoying

Completed

Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial

Glioma | Radiotherapy, Intensity-Modulated | Maximum Tolerated Dose
University Hospital Regensburg

Completed

Impact of Bevacizumab on Symptom Burden and Neurological Deficits in Patients With Recurrent Glioblastoma

Glioblastoma | Angiogenesis

Germany
Haukeland University Hospital
University of Bergen

Terminated

The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas (Gliomstudien)

Glioblastoma Multiforme | Anaplastic Astrocytoma | Tumor Angiogenesis

Norway
Zhongnan Hospital

Recruiting

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Uterine Cervical Neoplasms | Angiogenesis | Chemoradiotherapy

China
Wuhan Union Hospital, China

Withdrawn

Safety and Efficacy Study of Chemotherapy Plus Apatinib as Second-line Therapy in Metastatic Colorectal Cancer (XHZL)

Colorectal Cancer | Chemotherapy | Angiogenesis
Taichung Veterans General Hospital

Unknown

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Glioblastoma Multiforme | Angiogenesis

Taiwan
Hannover Medical School

Completed

Value of Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage

Bile Duct Stricture Not Treatable by ERC

Germany
Zhongshan People's Hospital, Guangdong, China
Sun Yat-sen University Cancer Centre

Recruiting

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma (CTVp1-NPC)

Nasopharyngeal Carcinoma | Intensity-Modulated Radiotherapy

China
Hospital del Mar
Germans Trias i Pujol Hospital; Althaia Xarxa Assistencial Universitària de... and other collaborators

Active, not recruiting

Postoperative VEGF and Recurrence After Colon Cancer Surgery

Recurrence | Surgery | Colon Cancer | Angiogenesis | VEGF Overexpression
Sun Yat-sen University

Completed

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

Target Volume Delineation | Early-stage Nasopharyngeal Carcinoma | Intensity Modulated Radiation Therapy

China
The Affiliated Hospital of Qingdao University

Completed

The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy

NSCLC | Angiogenesis | Immunotherapy

China
JIANYANG WANG
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting

The Effect of Prophylactic TPO Combined With BMS-IMRT to Esophageal Cancer Patients

Esophageal Cancer | Thrombocytopenia | Concurrent Chemoradiotherapy | Intensity-modulated Radiation Therapy

China
Xinqiao Hospital of Chongqing

Not yet recruiting

Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

NSCLC | Radiotherapy | Immunotherapy | Intensity Modulated Radiation Therapy
Fujian Cancer Hospital

Not yet recruiting

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Small Cell Lung Cancer | Chemotherapy Effect | Angiogenesis
Sichuan Cancer Hospital and Research Institute

Unknown

Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer

Angiogenesis Inhibitors，Ovarian Neoplasms

China
Wuhan Union Hospital, China

Not yet recruiting

Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer

Carcinoma | Intrahepatic Cholangiocarcinoma | Gallbladder Cancer | Immunotherapy | Tislelizumab | Surufatinib | Angiogenesis Inhibitors | Antineoplastic Agents, Immunological
Gunma University
J~pharma

Completed

Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake (angiogenesis)

Non-Small Cell Lung Cancer | Angiogenesis

Japan
Royal Marsden NHS Foundation Trust

Completed

Parotid-sparing IMRT for Nasopharyngeal Cancer

Nasopharyngeal Cancers | Intensity Modulated Radiotherapy With Chemotherapy

United Kingdom
Sunnybrook Health Sciences Centre
Celgene

Completed

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS (REMMYDYS)

Myelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | Angiogenesis

Canada
University Hospital, Angers

Completed

Vascular Dysfunction and Antiangiogenic Therapy (DYVA-AAGG)

Solid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)

France
Recursion Pharmaceuticals Inc.

Recruiting

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Solid Tumor | APC Gene Mutation | AXIN1 Gene Mutation

United States
Samsung Medical Center

Active, not recruiting

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Cervix Cancer | Radiotherapy, Adjuvant | Radiotherapy, Intensity-Modulated | Hypofractionated Dose

Korea, Republic of
Samsung Medical Center

Active, not recruiting

Postoperative Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy in Cervical Cancer

Cervix Cancer | Radiotherapy, Adjuvant | Radiotherapy, Intensity-Modulated | Hypofractionated Dose | Chemotherapy, Concurrent

Korea, Republic of
Sun Yat-sen University

Recruiting

Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Paranasal Sinus Cancer | Induction Chemotherapy | Camrelizumab | Nasal Cavity Cancer | Intensity Modulated Radiotherapy | Concurrent Chemotherapy

China
Regina Elena Cancer Institute
University of California, San Diego; Lega Italiana per la Lotta contro i Tumori

Recruiting

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

PREDICTIVE BIOMARKERS | Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC | HPV 16 Positive Oropharyngeal Tumors (OPC)

Italy
Eastern Regional Medical Center

Recruiting

Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions

Loculated or Non-draining Malignant Pleural Effusions

United States
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Nanfang Hospital of Southern Medical University

Recruiting

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin | NPC | Carboplatin

China
CCTU

Active, not recruiting

NEO-SPACE Trial: Pembrolizumab and Chemoradiation in Nasopharyngeal Cancer

NPC

Hong Kong, Singapore
Wenjun Cheng

Not yet recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

Neoplasms by Histologic Type | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Ovarian Neoplasms | Fallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Angiogenesis | Genital Diseases, Female | Antineoplastic... and other conditions
National Cancer Institute (NCI)

Recruiting

Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer

Neoplasms | Esophageal Neoplasms | Esophagus Cancer | Esophagus Neoplasm | Neoplasms, Esophageal | Esophageal Cancer (EsC)

United States
Xiaoxiang Chen

Recruiting

Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (ANLOLA)

Neoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditions

China
AbbVie

Terminated

A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

Exocrine Pancreatic Insufficiency (EPI)

United States
Taichung Veterans General Hospital

Completed

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

Nasopharyngeal Carcinoma | Radiotherapy | EBV | NPC

Taiwan
Hai-Qiang Mai,MD,PhD
Zhejiang Cancer Hospital; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Not yet recruiting

The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study (CANPCSS)

NPC Patients
NeoImmuneTech
Bristol-Myers Squibb

Terminated

NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma

Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)

United States, Poland
National Cancer Institute (NCI)

Completed

Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China

Nasopharyngeal Cancinoma (NPC)

China
Xiaoxiang Chen

Unknown

Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (AVANIRA3)

Neoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Endocrine System Diseases | Ovarian Diseases | Adnexal Diseases | Gonadal Disorders | Endocrine Gland Neoplasms | Ovarian Neoplasms | Fallopian Tube Neoplasms and other conditions

China
Chinese University of Hong Kong

Completed

Nasopharyngeal Carcinoma (NPC) Axitinib

Recurrent or Metastatic NPC

Hong Kong
Affiliated Hospital to Academy of Military Medical...

Recruiting

LCI in Chronic Atrophic Gastritis and Early Gastric Cancer (non)

CAG - Chronic Atrophic Gastritis | EGC - Early Gastric Cancer

China
Hospices Civils de Lyon

Completed

Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan

Peritoneal Carcinosis (PC)

France
Dr Cipto Mangunkusumo General Hospital

Completed

Patogenic Mutation in 5 Genes

Colorectal Cancer | APC Gene Mutation | TP53 Gene Mutation | PIK3CA Gene Mutation | KRAS Mutation-Related Tumors | MLH1 Gene Mutation

Indonesia
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

Esophageal Squamous Cell Carcinoma (ESCC) | Gastroesophageal Junction Carcinoma (GEJC) | Esophageal Adenocarcinoma (EAC)

China, Canada, United States, Argentina, Belgium, Brazil, Chile, Czechia, Denmark, Estonia, France, Germany, Guatemala, Hong Kong, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Philippines, Portugal, Romania, Russian Federation and more

Clinical Trials on Angiogenesis Modulated by EPC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations